Metabo-Oncology

  • Metabo-Oncology, Emerging Key Player In Cancer Research and Treatment
    • Mission
    • Contributors
    • Publications
    • Contact
  • Expert Perspectives
    • Medical Treatment Perspectives
    • Exercise, Diet, Nutrition
    • Epidemiology — The Evidence Is Clear
    • Research: How Obesity Makes Cancer More Lethal
  • For Doctors
  • For Researchers
  • News & Events
News & Events

Insulin resistance in patients with cancer: a systematic review and meta-analysis

09.23.25

Marmol et al., 2023

https://www.tandfonline.com/doi/full/10.1080/0284186X.2023.2197124

News & Events

Sign Up

Join our mailing list for future updates.

View all News & Events
09.23.25

Insulin resistance in patients with cancer: a systematic review and meta-analysis

06.24.20

Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer

…insulin signaling can be seen as enabling tumor development by providing a mechanism for PI3K activation and enhanced glucose uptake. This idea is supported by studies showing enhanced tumor development in humans and mice with hyperinsulinemia, and reduced tumor development in states of reduced insulin levels.

© 2025 Metabo-Oncology. All Rights Reserved.

  • Privacy Policy
  • Terms of Use

Website by Metropolis Creative